Atrol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Atrol

Quick Facts

Property Description
Active ingredient Cetirizine Hydrochloride
Form Oral tablet, syrup, oral solution
Pharmacological class Second-generation antihistamine
Common use Anti-allergic agent
Origin Synthetic, metabolite of hydroxyzine

What Type of Medicine Is Atrol (Cetirizine)?

Atrol is a synthetic pharmaceutical preparation whose active ingredient is Cetirizine Hydrochloride, classified as a second-generation antihistamine and a selective peripheral H1-receptor blocker. This agent functions as a potent systemic anti-allergic agent. Chemically, it is a derivative, specifically a carboxylated metabolite of hydroxyzine, and a second-generation piperazine derivative. This classification defines its pharmacological profile, as its high selectivity for peripheral histamine receptors is designed to limit central nervous system effects compared to older antihistamine compounds.

Composition and Available Forms of Atrol

The essential composition of Atrol is a single-ingredient product, containing solely the therapeutic compound Cetirizine Hydrochloride. This active ingredient is optimized for oral administration and is supplied in several distinct dosage forms, including the standard oral tablet, a liquid syrup, and an oral solution formulation. The drug's pharmacological category and availability across these pharmaceutical forms are established features of its clinical presentation. The provision of both solid and liquid forms, such as the syrup or oral solution, allows for flexible usage for different patient needs.

What is the General Purpose of This Anti-Allergic Agent?

The general purpose of Atrol is to serve as an anti-allergic agent by mitigating the physical effects that occur due to the release of histamine in the body. The mechanism is achieved through its primary physiological action of selective antagonism toward the histamine H1-receptor. This peripheral H1-receptor blockade interrupts the biological cascade triggered by histamine release. For instance, in a typical use scenario, the medicine helps the body reduce common reactive symptoms, such as generalized itching or localized swelling, associated with allergic manifestations.

Regulatory References

  1. Cetirizine - StatPearls - NCBI Bookshelf

What side effects are possible with Atrol?

Possible Side Effects and Safety Information

The safety profile of Atrol (Atorvastatin) is classified by regulatory authorities based on the frequency and type of adverse reactions observed in clinical trials and post-marketing surveillance. This information organizes potential effects across different system-organ classes.


Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized according to standard frequency bands:

  • Common (1/100 to <1/10): Reactions frequently listed include nasopharyngitis, headache, diarrhoea, nausea, and musculoskeletal issues such as myalgia (muscle pain) and arthralgia (joint pain).
  • Uncommon (1/1,000 to <1/100): These include insomnia, dizziness, vomiting, and alopecia (hair loss).
  • Rare (1/10,000 to <1/1,000): Reactions such as thrombocytopenia, peripheral neuropathy, and serious muscle events like rhabdomyolysis and myopathy are classified here.
  • Very Rare (<1/10,000): This category includes severe reactions like anaphylaxis and hepatic failure.

Serious Safety Concerns and Restrictions

Official labeling specifically documents rare but serious adverse reactions, notably rhabdomyolysis and hepatic failure, which are significant safety considerations requiring monitoring. The label also addresses safety constraints for specific patient groups:

  • Contraindications: The medicine is formally contraindicated in patients with active liver disease and during pregnancy and lactation. Use is also restricted with certain co-administered drugs.
  • Safety Monitoring: The regulatory documents mandate that monitoring of liver enzymes (before treatment initiation and as clinically indicated) and creatine kinase (CK) levels should be performed to detect potential muscle and liver toxicity. Furthermore, post-marketing reports include generally reversible cognitive impairment and increases in blood glucose levels.

Overdose and Emergency Response

The official regulatory documentation states that there is no specific acute treatment or symptom profile documented solely for overdosage of Atrol (Atorvastatin). Overexposure primarily results in the amplification of serious adverse effects already associated with the medicine.

The principal concern is the potential for severe musculoskeletal toxicity, known as myopathy, characterized by muscle pain, tenderness, or weakness, and significant elevation of serum creatine kinase (CK) levels. Overdose may escalate this risk to rhabdomyolysis, a potentially life-threatening condition that can result in acute kidney injury. Furthermore, regulatory information notes the risk of hepatotoxicity, including increases in serum transaminases and, rarely, reports of hepatic failure.

Immediate medical attention is required for any suspected overdose. Because no specific antidote is known, the management protocol is strictly limited to providing symptomatic treatment and necessary supportive measures. Due to the drug's high plasma protein binding, hemodialysis is not expected to significantly enhance clearance. Patients are mandated to promptly report unexplained muscle symptoms, fever, or malaise to emergency services. Increased risk for myopathy is noted in patients with renal impairment and the elderly.

Therapeutic Uses of Atrol

Quick Facts

  • Goal: Used to help manage elevated lipid levels, including total cholesterol and low-density lipoprotein cholesterol (LDL-C).
  • Cardiovascular Support: Can help reduce the likelihood of major cardiovascular events such as myocardial infarction (MI), stroke, and certain revascularization procedures.
  • Conditions Addressed: Used as an adjunct to diet for primary hyperlipidemia, mixed dyslipidemia, and certain forms of familial hypercholesterolemia.

Atrol (referring to the active ingredient Atorvastatin) is a medication utilized in the management of elevated lipid levels in the blood, including total cholesterol, LDL-C, apolipoprotein B, and triglycerides. This medication is typically used alongside dietary changes and lifestyle modifications to help optimize a patient's lipid profile.

The primary therapeutic goal is to help reduce the risk of serious cardiovascular complications. For adults who have multiple risk factors for coronary heart disease (CHD) but without existing CHD, Atrol may be used to help reduce the likelihood of a heart attack (MI), stroke, and the need for revascularization procedures. Patients with type 2 diabetes and multiple CHD risk factors may also utilize this treatment to help address the risk of MI and stroke.

Furthermore, for patients with established CHD, Atrol can be utilized to help mitigate the risk of non-fatal MI, fatal and non-fatal stroke, and hospitalizations for congestive heart failure. The medication is an approved treatment for various forms of hyperlipidemia in adults and is also indicated for use in certain pediatric patients with heterozygous familial hypercholesterolemia (HeFH).

Eligibility and Restrictions for Use

Who can and cannot use Atrol (Atorvastatin)

The population eligibility for Atrol is defined by regulatory guidelines, outlining groups that are permitted, restricted, or strictly prohibited from use.

Category Regulatory Status
Allowed Populations Adults; Pediatric patients aged 10 years and older for specific cholesterol conditions.
Contraindicated Populations Patients with active liver disease or unexplained persistent elevations of liver enzymes; Patients with known hypersensitivity to the medicine.

Absolute Regulatory Prohibitions:

  • Pregnancy and Lactation: Use is contraindicated during pregnancy due to the risk of fetal harm and is also contraindicated while breastfeeding.
  • Reproductive Potential: Women of child-bearing potential must use adequate contraception.

Conditional Use and Restrictions:

  • Age: Use is not established in children younger than 10 years of age. Advanced age (over 65 years) is noted as a risk factor for myopathy.
  • Comorbidities: Caution is required in patients with renal impairment, uncontrolled hypothyroidism, or a history of liver disease, as these are documented predisposing risk factors for muscle-related complications.

What should I know about interactions with other medicines?

The official regulatory profile for Atrol (Atorvastatin) establishes constraints on co-administration based on documented pharmacokinetic and pharmacodynamic interactions. Co-administration with Cyclosporine and specific antiviral combinations, including Glecaprevir plus Pibrentasvir, is formally prohibited due to the potential for significantly increased systemic exposure of Atorvastatin.

Combining Atorvastatin with other drugs that increase muscle risk, such as Fibric Acid Derivatives, Colchicine, and Niacin at doses ge 1 g/day, heightens the documented risk for myopathy and rhabdomyolysis.

Inhibitors of the CYP3A4 enzyme (e.g., Itraconazole) and certain transporters (e.g., OATP1B1) increase Atorvastatin plasma concentrations. Conversely, co-administration with inducers like Rifampin or the herbal product St. John’s Wort may reduce Atorvastatin levels. The label requires Rifampin to be administered simultaneously with Atorvastatin to maintain exposure. Consumption of Grapefruit Juice must be limited to le 1 liter per day.

Atorvastatin itself is documented to increase the plasma concentration of Digoxin and the active components of Oral Contraceptives. A population-specific caution notes that patients with Hepatic Impairment exhibit markedly increased Atorvastatin plasma levels.

Mechanism of Action

Atrol (also known as Atropine) functions as a competitive, reversible antagonist primarily targeting the muscarinic acetylcholine receptors (mAChR) throughout the body, including the M1, M2, M3, M4, and M5 subtypes.

Atrol exhibits high affinity for these receptors on various tissues, including cardiac tissue, smooth muscle, and exocrine glands. By occupying the orthosteric binding site, the compound prevents the binding and activation of the endogenous neurotransmitter acetylcholine.

This antagonism disrupts the parasympathetic nervous system signaling cascade. Specifically, the blockade of M2 receptors in the sinoatrial (SA) and atrioventricular (AV) nodes of the heart removes the vagal inhibitory tone, leading to an increase in heart rate and AV conduction velocity. Blockade of M3 receptors on smooth muscle, such as in the bronchial and gastrointestinal tracts, results in the relaxation of smooth muscle and decreased gastrointestinal motility. Blockade on exocrine glands reduces secretions from salivary, bronchial, and sweat glands.

Dosage and Administration Information

How to Use Atrol (Atorvastatin) — Administration Guidelines

Atrol is prescribed for chronic, once-daily oral administration. The dosing and administration rules are structured to ensure consistency with approved labeling.


Administration Scope Detail
Route of administration The medicine must be taken orally (by mouth).
Dosing schedule (Adults) The authorized daily dosage ranges from 10 mg to a maximum of 80 mg once daily. The starting dose is typically 10 mg or 20 mg.
Timing in relation to meals Tablets may be taken with or without food and at any time of the day. Oral Suspension (where approved) must be taken on an empty stomach.
Age-group administration rules Pediatric (10-17 years) with HeFH: Starting dose is 10 mg; maximum is 20 mg daily. Adults/Geriatric: No routine dose adjustment is specified for older adults or renal impairment.
Missed-dose rules If a dose is missed, the user must skip the missed dose and take the next scheduled dose at the usual time; doubling the dose is not permitted.
Special procedural conditions The film-coated tablets must be swallowed whole; they should not be crushed or chewed. Dosage adjustments based on laboratory assessments should occur at intervals of four weeks or longer.

Resulting Procedural Structure

The established protocol establishes a standardized once-daily oral schedule that permits administration flexibility regarding the time of day and meal intake for the tablet form. This framework defines the 10 mg to 80 mg daily dose range and mandates that any dosage adjustment procedure must be spaced by at least four weeks. The instructions require long-term administration and explicit adherence to the dose-skipping rule if a daily dose is missed.

Recent Clinical Evidence

Research Evidence for Atrol


Evidence for Use in Seasonal and Perennial Allergic Rhinitis

Research has explored Atrol for use in conditions characterized by fluctuating or episodic manifestations, such as seasonal and perennial allergic rhinitis (hay fever and year-round nasal allergies). Studies have been applied in trials assessing short-term or episodic symptom patterns and used in research examining symptom intensity or variability. These studies often monitored patient-reported outcomes describing perceived discomfort linked to inflammatory or irritative states, such as a runny nose and sneezing.

The findings describe patterns observed in the studies where Atrol was observed in some studies to be associated with changes in outcomes related to physical discomfort during the study period. This evidence contributes to the broader evidence landscape on outcomes related to physical discomfort like a runny nose, sneezing, and itchy eyes associated with these conditions.


Evidence for Use in Chronic Idiopathic Urticaria (Hives)

Atrol was evaluated in research exploring outcomes related to the symptoms of chronic hives, which are conditions involving periods of heightened symptoms without a known cause. This research examined outcomes capturing phases of heightened symptom activity, particularly focusing on the intensity of itching and the appearance of rashes, which are outcomes linked to inflammatory or irritative states.

Clinical trials and other research explored Atrol's use in settings with varying symptom burdens. Studies report how symptoms evolved in the observed populations, and data show patterns related to changes in the frequency and severity of hives and associated itching. This evidence provides insight into short-term changes measured in these study contexts.


Long-term Studies and Follow-up

This section summarizes what research has explored regarding the effects of using Atrol over extended durations. Studies have examined the outcomes reflecting daily functioning or activity level over defined time intervals beyond the initial treatment phase. Research describes the available data on the durability of patterns observed in symptoms, which is the extent to which effects appear to last over time.

A key limitation is that there is limited information for long-term outcomes for many treatments, including Atrol, and follow-up durations were limited in much of the available published research. Consequently, long-term effects are not fully established, and research is ongoing.


What is Still Uncertain About Atrol

This section clarifies where evidence gaps exist in the current research for Atrol. While many studies have been completed, findings were mixed or inconsistent in specific areas, and comparative evidence is lacking for some questions. The research explores the observed patterns, but the results apply only to the populations studied. This evidence highlights what is known — and what is still uncertain, indicating where additional research is needed.

Key Studies & References

  1. Cetirizine: a review of its use in allergic disorders
  2. Clinical studies with cetirizine in allergic rhinitis and chronic urticaria
  3. Label: CETIRIZINE HCL- cetirizine tablet (DailyMed / FDA)

Frequently Asked Questions (FAQ)

Common questions about Atrol (FAQ)

Q: What does 'contraindication' mean when official documents discuss Atrol?

A: A contraindication is a factor or condition that prohibits the use of a medicine because the potential harm outweighs any potential benefit. According to official documents, this is why conditions such as active liver disease or pregnancy serve as formal reasons to withhold the medicine.


Q: Do I need to change my diet while using Atrol?

A: The official product information states that the tablet form of Atrol can be taken without regard to food, offering flexibility in administration. However, official labeling states that consumption of grapefruit juice should be limited to no more than one liter per day due to the possibility of increased drug levels and an elevated risk of side effects.


Q: How long does the effect of a dose of Atrol typically last?

A: Atrol is generally prescribed for once-daily administration, which indicates that the medicine is designed to have an effect for approximately 24 hours. The duration of activity is generally described as lasting until the next scheduled dose.


Q: Why are certain medical conditions listed as reasons not to use Atrol?

A: Certain conditions, notably active liver disease, are listed as restrictions because official safety documents indicate that the medicine can increase the risk of adverse reactions. These risks include the potential for hepatic failure (severe liver problems) or serious muscle-related complications.


Q: What is the difference between a 'side effect' and an 'adverse reaction' for Atrol?

A: Official regulatory documents use both terms to categorize unfavorable events reported during use. An adverse reaction is a specific, documented, and formally categorized unfavorable effect that is classified by its frequency and reported to health authorities.


Q: Can the effectiveness of Atrol vary significantly between different people?

A: Studies and official information describe patterns suggesting that a person's response to the medicine may vary. Factors such as advanced age, renal impairment (kidney problems), or genetic differences in how the body processes the drug are noted as factors that can influence its effect and safety profile.


Q: Does Atrol affect the results of any common medical tests?

A: The medicine may cause changes in specific lab markers. These include increases in liver enzymes, creatine kinase (CK) (a muscle enzyme), and blood glucose (sugar) levels, which are markers noted for safety monitoring.


Q: What are the ingredients in Atrol besides the active component?

A: Official documents list the therapeutic active ingredient and all inactive ingredients (excipients) used to form the final product, whether it is a tablet, syrup, or solution. The inactive components are necessary for the structure and stability of the medicine.


Q: What is the maximum duration of use recommended in official documents for Atrol?

A: The medicine is prescribed for chronic, long-term oral administration for its intended uses. Accordingly, the official documents do not define a specific maximum duration or time limit for its use.


Q: Can Atrol be taken by people who are healthy, or only by those with a specific condition?

A: The official product information describes the medicine as intended for the treatment of specific conditions, such as high cholesterol or certain allergic states, as defined by regulatory bodies. It is also contraindicated (must not be used) in specific patient populations, such as those with active liver disease.


Q: How quickly can I expect to notice any effects from Atrol?

A: According to official pharmacokinetics data, the medicine begins working quickly. Depending on the formulation, the antihistamine effect may begin within 20 minutes to one hour, and the peak concentration of the statin component can be reached in about 1 to 2 hours.


Q: Are there any common supplements that should be avoided when taking Atrol?

A: Regulatory documents specifically mention that the herbal product St. John's Wort is a potential interaction concern. This supplement may reduce the concentration (systemic exposure) of the medicine in the body.


Q: Is Atrol considered a controlled substance?

A: Based on federal classifications, the active components of Atrol (Atorvastatin and Cetirizine) are not listed as controlled substances. This means they are not subject to the same strict prescribing and storage regulations as narcotics or certain sedatives.


Q: Can Atrol interact with common over-the-counter pain relievers?

A: Most common over-the-counter pain relievers are not explicitly listed as major contraindications with this medicine. However, caution is noted regarding high doses of Acetaminophen due to the potential for an increased combined risk of liver issues.


Q: How long after stopping Atrol does it stay in the body?

A: The medicine's active components have a half-life of approximately 14 hours, meaning that half the drug has left the body in that time. However, some active breakdown products (metabolites) can have an extended half-life of up to 20 to 30 hours.


Q: Are there any known interactions between Atrol and alcohol?

A: The medicine can increase the risk of liver problems, and official warnings state that consuming substantial quantities of alcohol is noted to increase this risk. Alcohol can also increase side effects like dizziness and drowsiness.


Q: Can Atrol cause mood changes?

A: The medicine has been associated with less frequent, generally reversible effects on the central nervous system. These documented side effects include cognitive impairment (issues with thinking) and confusion.


Q: Are there any warnings about driving or operating machinery while taking Atrol?

A: Official counseling information states that due to the potential for side effects like dizziness or drowsiness, activities requiring mental alertness, such as driving or operating hazardous machinery, should be avoided until one knows how the medication affects them.


Q: Does Atrol require a prescription, or is it over-the-counter?

A: Official administration documents indicate that some formulations of the medicine are only available with a prescription. However, other formulations of the active ingredient are widely available over-the-counter.


Q: How is Atrol generally eliminated from the body?

A: According to official pharmacokinetics data, the medicine and its active components are primarily eliminated from the body through biliary excretion (via the bile). A smaller portion is eliminated through the kidneys (urinary excretion).

How should Atrol be stored and disposed of?

How to Store and Dispose of Atrol (Atorvastatin)

Official regulatory guidelines strictly define the conditions necessary for storing and handling Atorvastatin tablets.


Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, specifically 20 C to 25 C (68 F to 77 F).
Container Rule Keep the medicine in its original container and ensure the container is tightly closed.
Protection The product must be protected from excess heat and excess moisture.
Child Safety Keep this medication strictly out of the sight and reach of children.

Disposal Instructions

Unused or expired Atorvastatin should be disposed of according to official regulatory guidance. The preferred method is returning the product through a local drug take-back program. If a take-back program is unavailable, the medication must be mixed with an undesirable substance (such as dirt or coffee grounds) and placed in a sealed bag before disposal in the household trash. Disposal should not occur via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Atrol found in:

A-Z Index: